excedrin migraine
Generic: acetaminophen, aspirin (nsaid) and caffeine
Labeler: jones healthcare group - packaging services, incDrug Facts
Product Profile
Brand Name
excedrin migraine
Generic Name
acetaminophen, aspirin (nsaid) and caffeine
Labeler
jones healthcare group - packaging services, inc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67414-239
Product ID
67414-239_27ecdf5e-bc7a-12ee-e063-6394a90ad246
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2018-01-24
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67414239
Hyphenated Format
67414-239
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
excedrin migraine (source: ndc)
Generic Name
acetaminophen, aspirin (nsaid) and caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 2000 POUCH in 1 BOX (67414-239-02) / 2 TABLET, FILM COATED in 1 POUCH
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "27ecdf5e-bc7a-12ee-e063-6394a90ad246", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["c4168e4d-3dfc-4e51-a32e-14704cb59c66"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Jones Healthcare Group - Packaging Services, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2000 POUCH in 1 BOX (67414-239-02) / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67414-239-02", "marketing_start_date": "20180124"}], "brand_name": "EXCEDRIN MIGRAINE", "product_id": "67414-239_27ecdf5e-bc7a-12ee-e063-6394a90ad246", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "67414-239", "generic_name": "Acetaminophen, Aspirin (NSAID) and Caffeine", "labeler_name": "Jones Healthcare Group - Packaging Services, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "EXCEDRIN", "brand_name_suffix": "MIGRAINE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20180124", "listing_expiration_date": "20261231"}